Home
TPST
TPST News

Latest Tempest Therapeutics Inc. (TPST) News on July 27, 2024

Argus Research

18 days ago

Daily – Vickers Top Buyers & Sellers for 07/09/2024

Argus Research

22 days ago

Daily – Vickers Top Buyers & Sellers for 07/05/2024

Argus Research

24 days ago

Daily – Vickers Top Buyers & Sellers for 07/03/2024

Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm

GlobeNewswire

a month ago

Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm

Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma

GlobeNewswire

a month ago

Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Tempest to Participate in Upcoming Investor Conferences

GlobeNewswire

2 months ago

Tempest to Participate in Upcoming Investor Conferences

Tempest Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

3 months ago

Tempest Reports First Quarter 2024 Financial Results and Provides Business Update

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting

GlobeNewswire

4 months ago

Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting

Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications

GlobeNewswire

4 months ago

Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications

Tempest Reports Year End 2023 Financial Results and Provides Business Update

GlobeNewswire

4 months ago

Tempest Reports Year End 2023 Financial Results and Provides Business Update

Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types

GlobeNewswire

5 months ago

Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types

Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting

GlobeNewswire

5 months ago

Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting

Tempest to Present at the 44th Annual TD Cowen Healthcare Conference

GlobeNewswire

5 months ago

Tempest to Present at the 44th Annual TD Cowen Healthcare Conference

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

HMN Financial Inc. Reports Decreased Earnings in Q4 and Full Year 2023, Declares Dividend

GuruFocus.com

6 months ago

HMN Financial Inc. Reports Decreased Earnings in Q4 and Full Year 2023, Declares Dividend

Health Care Roundup: Market Talk

The Wall Street Journal

7 months ago

Health Care Roundup: Market Talk

Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH

Business Wire

7 months ago

Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH

Business Wire

7 months ago

First Trust Energy Infrastructure Fund Declares its Monthly Common Share Distribution of $0.10 Per Share for January

David Nierenberg Increases Stake in Flotek Industries Inc

GuruFocus.com

7 months ago

David Nierenberg Increases Stake in Flotek Industries Inc

Associated Press Finance

7 months ago

Conn's: Fiscal Q3 Earnings Snapshot

Conn’s, Inc. Reports Third Quarter Fiscal Year 2024 Financial Results

GlobeNewswire

7 months ago

Conn’s, Inc. Reports Third Quarter Fiscal Year 2024 Financial Results

First Trust Energy Infrastructure Fund Issues Notice Regarding December 2023 Distribution

Business Wire

7 months ago

First Trust Energy Infrastructure Fund Issues Notice Regarding December 2023 Distribution

5 Under-$15 Stocks Wall Street Analysts Recommend Buying

Zacks

7 months ago

5 Under-$15 Stocks Wall Street Analysts Recommend Buying

Alto Ingredients, Inc. Publishes Sustainability Summary

GlobeNewswire

8 months ago

Alto Ingredients, Inc. Publishes Sustainability Summary

Is It Smart To Buy First Capital, Inc. (NASDAQ:FCAP) Before It Goes Ex-Dividend?

Simply Wall St.

8 months ago

Is It Smart To Buy First Capital, Inc. (NASDAQ:FCAP) Before It Goes Ex-Dividend?

Associated Press Finance

8 months ago

Urban One: Q2 Earnings Snapshot

Associated Press Finance

8 months ago

Urban One: Q1 Earnings Snapshot

ACCO Brands Corporation Announces Appointment of Beth Simermeyer to Board of Directors

Business Wire

8 months ago

ACCO Brands Corporation Announces Appointment of Beth Simermeyer to Board of Directors

Associated Press Finance

8 months ago

Urban One: Q3 Earnings Snapshot

INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium

GlobeNewswire

8 months ago

INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium

PR Newswire

8 months ago

VIRGINIA NATIONAL BANKSHARES CORPORATION ANNOUNCES QUARTERLY CASH DIVIDEND

Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference

GlobeNewswire

8 months ago

Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference

UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

GlobeNewswire

8 months ago

UPDATE – Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update

Digital Turbine, Inc. (NASDAQ:APPS) Q2 2024 Earnings Call Transcript

Insider Monkey

9 months ago

Digital Turbine, Inc. (NASDAQ:APPS) Q2 2024 Earnings Call Transcript

Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire

9 months ago

Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update

ARC Document Solutions, Inc. (NYSE:ARC) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

ARC Document Solutions, Inc. (NYSE:ARC) Q3 2023 Earnings Call Transcript

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

GlobeNewswire

9 months ago

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

Share on Social Networks: